Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
Hlavní autoři: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Springer Nature
2017
|
Podobné jednotky
-
Pentoxifylline in patients with oral submucous fibrosis
Autor: Ashwini Deshpande, a další
Vydáno: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
Autor: Santosh Patil, a další
Vydáno: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
Autor: Yifan Lin, a další
Vydáno: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
Autor: Arun S, a další
Vydáno: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
Autor: Hiren A. Dhameliya, a další
Vydáno: (2020-05-01)